Biotech firm Valneva works on an inactivated whole-virus vaccine against COVID-19 in Vienna
A biologist at the French-Austrian biotech firm Valneva works on an inactivated whole-virus vaccine against COVID-19 in a laboratory in Vienna, Austria, December 16, 2021. REUTERS/Lisi Niesner